Skip to main content

Leo Pharma Taps Intomics for Data Services

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bioinformatics contract research firm Intomics will provide its services to Leo Pharma for early drug discovery applications, Intomics said today.

A recent spin-off from The Danish Technical University, Intomics will provide data mining and analysis services for a range of Leo Pharma's research projects.

An independent company owned by the Leo Foundation, Leo Pharma is focused on developing drugs for dermatology and critical care applications, including treatments for psoriasis and other skin diseases, as well as thromboembolisms.

Financial terms of the agreement were not released.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.